NeoGenomics is transitioning from a commodity diagnostic provider to a comprehensive precision oncology platform. Read why ...

SALT LAKE CITY - Co-Diagnostics, Inc. (NASDAQ:CODX) announced Monday that the Australian Patent Office has granted the company its first patent for its point-of-care PCR testing platform. The microcap ...

As the nation experiences what many experts believe is the second-largest wave of COVID infections since the pandemic started, many Americans will be checking to make sure they don’t have the ...

Northwestern scientists have created the fastest-ever hepatitis C diagnostic, delivering accurate results in only 15 minutes. The test uses the DASH rapid PCR system, originally developed for COVID, ...

Veterans Day 2025 is observed today, Nov. 11 to celebrate and honor those who served or continue to serve our country, with restaurants offering free meals, deals, discounts, and freebies to veterans ...

Patients in rural communities often lack timely access to innovative infectious disease testing because diagnostic laboratories are located far away. Long transport times and logistical barriers delay ...

Oct 6 (Reuters) - Ferrari (RACE.MI), opens new tab has completed the construction of e-Vortex, the new test circuit next to its Fiorano test track in less than four months, the sports car maker said ...

Fort Bragg announced it will begin sampling soil from some residential areas this month to assess lead levels in the ground. The soil sampling will focus on neighborhoods with homes built before 1978, ...

A new biotechnology company in McKinney has ambitions to become the world’s first fully integrated platform for polymerase chain reaction (PCR) testing — the same technology behind a common COVID-19 ...

The founder and former CEO of 23 and Me is set to regain control of the company. Anne Wojcicki won a bid to purchase the genetic testing platform through her nonprofit TTAM Research Institute. The ...

Nucleus Genomics, a genetic testing startup founded by 25-year-old Kian Sadeghi, initially launched in 2021 with the goal of calculating a patient’s risk for specific diseases. But it’s been courting ...